Biocon Announces 48th AGM and E-voting Information
Biocon Limited will hold its 48th AGM on August 06, 2026, via VC/AVM. Remote e-voting is open from August 01 to August 05, 2026. A final dividend of 10% (₹0.50 per share) was approved for FY2025-26, with payment expected by August 20, 2026, post-approval.
The announcement pertains to standard corporate governance procedures (AGM) and dividend declaration, which are expected events for listed companies and typically have a minimal immediate impact on the stock price.
The announcement is a routine disclosure of AGM details and dividend information, with no significant positive or negative financial implications presented.
Biocon Limited has published a notice regarding its 48th Annual General Meeting (AGM) and e-voting information. The AGM is scheduled to be held on Thursday, August 06, 2026, at 3:30 PM IST through Video Conferencing (VC) or Other Audio-Visual Means (AVM). The company has sent the Notice of the 48th AGM along with the Integrated Annual Report for FY 2025-26 to members whose email addresses are registered. Members can access these documents on the company's website (www.biocon.com), stock exchange websites (www.bseindia.com and www.nseindia.com), and the RTA's website (https://evoting.kfintech.com/).
The cut-off date for determining eligibility to vote is Thursday, July 30, 2026. The remote e-voting period will commence on Saturday, August 01, 2026, at 9:00 AM IST and will conclude on Wednesday, August 05, 2026, at 5:00 PM IST. Members will also have the facility to e-vote during the AGM through Insta-Poll. The company has appointed Mr. V Sreedharan and Mr. Pradeep B Kadam as Scrutinizers for the remote e-voting process and Insta-poll.
Furthermore, the Board of Directors, in their meeting held on May 07, 2026, approved a final dividend of 10% (₹0.50 per equity share) for the Financial Year ended March 31, 2026. The record date for determining entitlement for this dividend is Friday, July 03, 2026, and the payment is scheduled for Thursday, August 20, 2026, subject to member approval at the AGM.
What to do with a filing like this
Biocon Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Biocon Limited. Read the original for the full detail.